| Tag | Content |
|---|
EnhancerAtlas ID | HS092-24933 |
Organism | Homo sapiens |
Tissue/cell | HFF |
Coordinate | chr2:162020900-162023320 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| Lhx3 | MA0135.1 | chr2:162021071-162021084 | TGTTAATTAATTT | - | 6.19 | | Nkx3-2 | MA0122.3 | chr2:162021919-162021932 | TTTAAGTGGTTTT | - | 7.52 | | SPI1 | MA0080.4 | chr2:162022499-162022513 | AAAAAAAGGAAGTA | + | 6.3 | | SPIC | MA0687.1 | chr2:162022499-162022513 | AAAAAAAGGAAGTA | + | 6.79 |
|
| | Number of super-enhancer constituents: 2 | ID | Coordinate | Tissue/cell |
| SE_09670 | chr2:162015575-162030985 | CD14 | | SE_11151 | chr2:162011838-162029041 | CD20 |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH02I161162 | chr2 | 162019460 | 162025018 |
|
Enhancer Sequence | CCACCTGTTA TCTCCTATGC TTGCTGCCAT GGTTTTGAAT CATAAATACA GGGAAAGAGG 60
AGGCTATTAT TTAGATATGT AACAAAAATC GCTTTATAGT TCGGAACCAA GATTATGATT 120
ATCTTCAGGA AGGGATAACA GAATATGAAA TGAACTACCT TTTCAGTGAG TTGTTAATTA 180
ATTTTCAAAG TCTTTTGAAC TAAGTGCAGT ATTTGGTCAC TGTTCAAATA AGTTGAGGGT 240
AACTGGTACC AAGCCCTATG CAACTGAAAA CAGGCTTTGG GACTTATGTA GTACATGTGT 300
CACATTTTCC AATTCCTAAT CTATAAAAGC TTTTTAAATT GTGGTAAAAT TCACATAACA 360
TAAAATTTAC CATCTTAACC TTTTTTTAAA GTATATGGTT CAATAATGTT AAGTGCATTC 420
ACATTGCTAT GCAACCAAGA AAAACATTTT TAAAGGGACG TATTTTTCTT AAGGAAAAGA 480
GTTTGGGAAG TAAATGATGG CAATTGTTTG TCTCATGGAA AATTTCCTGG ACAGTAACTT 540
TTTACCTTCA GAGATATATT CTCTATAAAT GGTAATTATC AGTAGTAAGT TATGAGAGTA 600
AACATTTTGA GTACTAGTGA TCTATAATAG CTTTTACTTA ACACCAATAC TTTTTTTTTT 660
TTTTTTTTTT TGCAAAAGGA AGGGTCTACT GAAAATAGGT TGCTAACATT GACAACAAAG 720
TATTTTAAGT CATTGCAGTA AGGAATTACT GGAAATTGAG TAGACAAAGA AAATTAATAT 780
GAGTTCCATT TTGATGGTTA CTTAGCAAGT TGAACTTATG AGAGTCTTTG AAATAGTTGC 840
AGTATGAGAA TTGTTCTATT GAACAGCGAA ACAACCCAAT CAGGTAATAG TTTTTCCAGA 900
GAGTGACTTG CTATAAGGGA CAGAAGTTAG AGACTTAGAT TCTTTCAAAA TAAAGGATTT 960
TTTTTAATTG CTTGAAGAAG GATTTTTGGA ATCAGCAAAT CAACTGTTAT TGTGAGAGAT 1020
TTAAGTGGTT TTACTATTCA CAACCATTTA TTATGTGGCA TTTACTGGAA TGTGGTTTCA 1080
TAACCTCAAG TATTTGGAAT CCCAAAAGTA GAAATGCCTT TCCCTTGAGA TTGTTGTTTC 1140
TCAACCTTTA AAAATCCATA TTTCCTTTCT GATAAACATT AAAATCTCAC AAATCCTAGA 1200
GGATTGTAAT ACATGTTCCT TCCCATACAG TCCTACTCCT CCTCTACACC TCACCATACT 1260
GACTACAGAC TTTCTCTTCT AGTTCCCTCA TCTGTGAATA TTATGCAAAG TCCTTCTTTA 1320
TATGATTTAT GTAATAGATT TTTAATATTA ACTATTTCAA AATTGTATAT CCTTCCTCCC 1380
CCATCTTCAG ATTCTAACAT TGCCCCTAGT CAGAGGAGAG GATACCCCTT AAAGATTACT 1440
CAGTTCAGCA CAGCCAACTG AGCAGTGCCA TGTTTACGTT CACCTCAGAG GAGTAGAACA 1500
TCACATGCCT GCTTTCCCTT TTGGTGTTAT ACTGTTTAGT TGTGCACTTA AACCCATAAC 1560
ATTTGATAAA TAGTCTCAGA GAAAGAAGTA TTACTGGAGA AAAAAAGGAA GTAAGGCAAA 1620
ACTGAGACTC ATGGGTGTGG TCTTTGACAG TGAAATCTTT TAGCTCTTGC AAGATCACAT 1680
AGAAAATTTC ACCAAGTTCT AACATCCAGC AAAATGGAGA ACATGTACTG GGGACCTTTG 1740
GGTTTAACCA GTGAGACTGT CTTGTTTATC CTGTTGCATT TAGCCTTCCA GCTTATGGAA 1800
AAATACAAAA TTCAAATTCT AACACTGCTG GATTTATGAT ATTTAAGGTT TCTATTATAT 1860
CAGCTGCCTG GATGGAGCAC AGAAACAGCG TAGTACAATA TGCTATGGGT ATATTCATGA 1920
CCAAAGTTTA CAATGTGGAA GGAGAATAGA AATGCAAGAG GTCAGTTGGG GAATTAGCTG 1980
CTTGTGTTAT ATAACTCCTT AAAAGTGGAA AATGATCACA AGTAAATGTG AGTAGTGACA 2040
GTTCTCTTCC ATTTCCTTTC TTCAGGTAAG GAAAACACAC TTAATATTTT TGAGTGTCTT 2100
TAAAGATCTT CCTAACCATC CAAAAGAGAA GATGTCTTAT TTATGTGTAT ATGTCGTGTT 2160
GTTGACTGAT TTTTTTGCTT TTTACTCCTG ATGTGTTTTG TGGGTGAGAA GGCAAGCATG 2220
TAACTAAGAT ACAGAAAAGA CCAAGATGTA GTGGGGCACA GTGGCTTGAC GCCTATAATC 2280
TCAACTACTC AGAAGGCTGA GGTGGAAGGA TTGCTTGAGG CGAGGAGTCC AGGCTGCAGT 2340
GGGCTATGAT TGCACCGCCA CACTTGCTGC ACTCTACCCT TGGGGGACAG AGTGAAGCTC 2400
TGTCTCAAAA AAAAAACAAA 2420
|
